Edith Gavis

3.0k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Edith Gavis is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Edith Gavis has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 38 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Edith Gavis's work include Liver Disease and Transplantation (44 papers), Liver Disease Diagnosis and Treatment (37 papers) and Gut microbiota and health (14 papers). Edith Gavis is often cited by papers focused on Liver Disease and Transplantation (44 papers), Liver Disease Diagnosis and Treatment (37 papers) and Gut microbiota and health (14 papers). Edith Gavis collaborates with scholars based in United States, Italy and Canada. Edith Gavis's co-authors include Jasmohan S. Bajaj, Andrew Fagan, Masoumeh Sikaroodi, Patrick M. Gillevet, Michael Fuchs, Douglas M. Heuman, James B. Wade, Leroy R. Thacker, Melanie B. White and Richard K. Sterling and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Edith Gavis

52 papers receiving 2.1k citations

Hit Papers

Microbiota transplant for hepatic encephalopathy in cirrh... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edith Gavis United States 24 1.3k 1.1k 805 465 324 52 2.1k
Ariel Unser United States 15 1.5k 1.1× 1.3k 1.2× 768 1.0× 585 1.3× 180 0.6× 23 2.1k
Andrew Fagan United States 31 2.1k 1.7× 1.5k 1.4× 1.7k 2.1× 646 1.4× 816 2.5× 89 3.5k
Shinya Furukawa Japan 26 1.2k 0.9× 527 0.5× 211 0.3× 245 0.5× 84 0.3× 144 2.1k
Antonio Gasbarrini Italy 21 460 0.4× 120 0.1× 535 0.7× 401 0.9× 214 0.7× 97 1.6k
Stephen Malnick Israel 22 710 0.6× 284 0.3× 216 0.3× 361 0.8× 84 0.3× 84 1.9k
Kook Lae Lee South Korea 22 736 0.6× 363 0.3× 232 0.3× 463 1.0× 104 0.3× 96 1.7k
Tien S. Dong United States 22 306 0.2× 162 0.2× 720 0.9× 156 0.3× 104 0.3× 84 1.5k
Walter Heldwein Germany 23 668 0.5× 622 0.6× 88 0.1× 1.0k 2.2× 59 0.2× 62 2.4k
Kyung Sik Park South Korea 27 428 0.3× 187 0.2× 350 0.4× 1.2k 2.6× 89 0.3× 149 2.6k
Oh Young Lee South Korea 27 401 0.3× 163 0.2× 382 0.5× 1.1k 2.4× 113 0.3× 138 2.5k

Countries citing papers authored by Edith Gavis

Since Specialization
Citations

This map shows the geographic impact of Edith Gavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Gavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Gavis more than expected).

Fields of papers citing papers by Edith Gavis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Gavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Gavis. The network helps show where Edith Gavis may publish in the future.

Co-authorship network of co-authors of Edith Gavis

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Gavis. A scholar is included among the top collaborators of Edith Gavis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Gavis. Edith Gavis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fagan, Andrew, Edith Gavis, Brian Davis, et al.. (2022). A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. Journal of Hepatology. 78(2). 312–321. 39 indexed citations
2.
Shamsaddini, Amirhossein, Andrew Fagan, Edith Gavis, et al.. (2021). Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. Journal of Hepatology. 76(3). 600–607. 20 indexed citations
3.
Acharya, Chathur, Tejasav S. Sehrawat, Deborah B. McGuire, et al.. (2021). Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study. Journal of Medical Internet Research. 23(4). e24639–e24639. 8 indexed citations
4.
Bajaj, Jasmohan S., Andrés Duarte‐Rojo, Jesse J. Xie, et al.. (2020). Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 18(13). 3008–3016.e2. 52 indexed citations
5.
Shamsaddini, Amirhossein, Chang Hu, Andrew Fagan, et al.. (2020). Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy. Journal of Hepatology. 74(1). 80–88. 18 indexed citations
6.
Bajaj, Jasmohan S., K. Rajender Reddy, Jacqueline G. O’Leary, et al.. (2020). Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology. 159(5). 1715–1730.e12. 81 indexed citations
7.
Bajaj, Jasmohan S., Edith Gavis, Andrew Fagan, et al.. (2020). A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder. Hepatology. 73(5). 1688–1700. 187 indexed citations
8.
Bajaj, Jasmohan S., Amirhossein Shamsaddini, Andrew Fagan, et al.. (2020). Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials. Hepatology Communications. 5(2). 258–271. 55 indexed citations
9.
Bajaj, Jasmohan S., Masoumeh Sikaroodi, Amirhossein Shamsaddini, et al.. (2020). Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy. Gut. 70(6). 1162–1173. 66 indexed citations
10.
Liu, Runping, Jason D. Kang, R. Balfour Sartor, et al.. (2019). Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. Hepatology. 71(2). 611–626. 82 indexed citations
11.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial. Hepatology. 70(5). 1690–1703. 226 indexed citations
12.
Duarte‐Rojo, Andrés, Sanath Allampati, Leroy R. Thacker, et al.. (2018). Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metabolic Brain Disease. 34(1). 289–295. 26 indexed citations
13.
Bajaj, Jasmohan S., Chathur Acharya, Andrew Fagan, et al.. (2018). Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. The American Journal of Gastroenterology. 113(8). 1177–1186. 89 indexed citations
14.
Bajaj, Jasmohan S., Andrew Fagan, Edith Gavis, et al.. (2017). Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis. Clinical and Translational Gastroenterology. 8(7). e108–e108. 52 indexed citations
15.
Patidar, Kavish R., Jawaid Shaw, Chathur Acharya, et al.. (2017). No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients With Cirrhosis and Infections. Clinical Gastroenterology and Hepatology. 15(11). 1803–1804. 6 indexed citations
16.
Nardelli, Silvia, Sanath Allampati, Oliviero Riggio, et al.. (2016). Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study. Digestive Diseases and Sciences. 62(3). 794–800. 16 indexed citations
17.
Bajaj, Jasmohan S., Vishwadeep Ahluwalia, Leroy R. Thacker, et al.. (2016). Brain Training with Video Games in Covert Hepatic Encephalopathy. The American Journal of Gastroenterology. 112(2). 316–324. 6 indexed citations
18.
Lauridsen, Mette Munk, Leroy R. Thacker, Melanie B. White, et al.. (2015). In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving. Clinical Gastroenterology and Hepatology. 14(5). 747–752. 24 indexed citations
19.
Allampati, Sanath, Andrés Duarte‐Rojo, Leroy R. Thacker, et al.. (2015). Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. The American Journal of Gastroenterology. 111(1). 78–86. 133 indexed citations
20.
Abou‐Assi, Souheil G., Anastasios A. Mihas, Edith Gavis, et al.. (2006). Safety of an Immune‐Enhancing Nutrition Supplement in Cirrhotic Patients With History of Encephalopathy. Journal of Parenteral and Enteral Nutrition. 30(2). 91–96. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026